Published in Clin J Am Soc Nephrol on January 21, 2009
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant (2010) 2.70
Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol (2010) 1.75
Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res (2011) 1.53
The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. Clin Nephrol (2010) 1.21
Osteoporosis--a risk factor for cardiovascular disease? Nat Rev Rheumatol (2012) 1.05
High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis. J Am Soc Nephrol (2015) 0.89
Evaluating bone quality in patients with chronic kidney disease. Nat Rev Nephrol (2013) 0.88
Vascular calcification and renal bone disorders. ScientificWorldJournal (2014) 0.88
Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol (2015) 0.87
Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int (2015) 0.87
The bone-vascular axis in chronic kidney disease. Curr Opin Nephrol Hypertens (2010) 0.87
The connections between vascular calcification and bone health. Nephrol Dial Transplant (2011) 0.85
Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients. Osteoporos Int (2009) 0.83
Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat. J Endocrinol (2015) 0.82
The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transplant (2010) 0.81
Bone disease after renal transplantation. Nat Rev Nephrol (2009) 0.81
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation. Kidney Int Suppl (2011) (2011) 0.78
Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension. Curr Hypertens Rep (2013) 0.78
Bone-vascular axis in chronic kidney disease: a reality? Clin J Am Soc Nephrol (2009) 0.78
Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study. Osteoporos Int (2014) 0.76
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol (2016) 0.75
Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients. PLoS One (2016) 0.75
Inflammation and the bone-vascular axis in end-stage renal disease. Osteoporos Int (2015) 0.75
Relationship Between Low Bone Mineral Density and Fractures With Incident Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Bone Miner Res (2017) 0.75
Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients. PLoS One (2017) 0.75
Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 10.70
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47
Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2005) 6.80
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2006) 5.69
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension (2001) 4.70
Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab (2004) 3.59
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int (2000) 2.72
Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis (1996) 2.22
Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol (2004) 2.10
Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06
Relationships of thoracic aortic wall calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J (2008) 1.38
Ethnic differences between extra-coronary measures on cardiac computed tomography: multi-ethnic study of atherosclerosis (MESA). Atherosclerosis (2007) 1.38
Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int (2008) 1.31
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant (2005) 1.29
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol (2008) 1.25
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol (2008) 1.22
Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest (2006) 1.22
Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int (2008) 1.20
Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant (2006) 1.17
Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Am Heart J (2006) 1.12
Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int (2003) 1.10
Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab (2006) 1.03
Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart (2006) 1.01
Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. Am J Nephrol (2007) 0.93
Evaluation of aortic arch calcification in hemodialysis patients. J Nephrol (2005) 0.87
Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells. Endocrine (2007) 0.85
Renal osteodystrophy in CAPD patients. Miner Electrolyte Metab (1984) 0.81
HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub-Saharan Africa. Int J Epidemiol (2011) 2.66
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int (2009) 2.60
Predictive comparison of joint longitudinal-survival modeling: a case study illustrating competing approaches. Lifetime Data Anal (2010) 2.38
Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int (2010) 2.16
Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol (2010) 2.06
A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int Suppl (2003) 2.04
Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women. Menopause (2012) 1.63
Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res (2011) 1.53
Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications. Hepatology (2014) 1.52
Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease. Clin J Am Soc Nephrol (2007) 1.44
Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res (2008) 1.26
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol (2008) 1.25
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis (2004) 1.23
Frequentist and Bayesian approaches to prevalence estimation using examples from Johne's disease. Anim Health Res Rev (2008) 1.16
Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol (2009) 1.14
Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int (2003) 1.10
Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol (2011) 1.05
The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? Nephrol Dial Transplant (2004) 1.01
Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure. Endocrinology (2003) 0.99
Accounting for response misclassification and covariate measurement error improves power and reduces bias in epidemiologic studies. Ann Epidemiol (2010) 0.96
Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder. J Bone Joint Surg Am (2013) 0.92
Comparison of two real-time reverse transcription polymerase chain reaction assays for the detection of Equine arteritis virus nucleic acid in equine semen and tissue culture fluid. J Vet Diagn Invest (2008) 0.92
EGFR/HER-targeted therapeutics in ovarian cancer. Future Med Chem (2012) 0.90
Work-related traumatic injuries onboard freezer-trawlers and freezer-longliners operating in Alaskan waters during 2001-2012. Am J Ind Med (2014) 0.90
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. Clin J Am Soc Nephrol (2013) 0.89
Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus. J Clin Microbiol (2009) 0.88
The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions. Vet Microbiol (2009) 0.87
On the interpretation of test sensitivity in the two-test two-population problem: assumptions matter. Prev Vet Med (2009) 0.86
Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test. Clin Vaccine Immunol (2007) 0.86
Absorbed EVELISA: a diagnostic test with improved specificity for Johne's disease in cattle. Foodborne Pathog Dis (2010) 0.85
Cervical cancer survival for patients referred to a tertiary care center in Kentucky. Gynecol Oncol (2011) 0.84
Bayesian approach to average power calculations for binary regression models with misclassified outcomes. Stat Med (2009) 0.83
Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss. Menopause (2013) 0.83
Bone biopsy: indications, techniques, and complications. Semin Dial (2003) 0.83
Effect of antioxidants on histamine receptor activation and sustained postexercise vasodilatation in humans. Exp Physiol (2015) 0.82
The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transplant (2010) 0.81
The effect of class a scavenger receptor deficiency in bone. J Biol Chem (2006) 0.81
Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity. J Cell Biochem (2014) 0.81
Disturbed synthesis of type II collagen interferes with rate of bone formation and growth and increases bone resorption in transgenic mice. Calcif Tissue Int (2008) 0.81
Effects of treatment of renal osteodystrophy on bone histology. Clin J Am Soc Nephrol (2008) 0.81
Bone disease after renal transplantation. Nat Rev Nephrol (2009) 0.81
Sample size calculations for ROC studies: parametric robustness and Bayesian nonparametrics. Stat Med (2011) 0.80
Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study. Am J Kidney Dis (2010) 0.80
No evidence of association between HIV-1 and malaria in populations with low HIV-1 prevalence. PLoS One (2011) 0.80
Acute exposure to high dose γ-radiation results in transient activation of bone lining cells. Bone (2013) 0.80
Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease. Nephrol Dial Transplant (2002) 0.78
FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis. Clin Nephrol (2014) 0.78
Effects of chronic heavy alcohol consumption and endurance exercise on cancellous and cortical bone microarchitecture in adult male rats. Alcohol Clin Exp Res (2014) 0.78
Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer. Cancer Invest (2013) 0.78
Retinoic acid receptor gamma 2 interactions with vitamin D response elements. J Steroid Biochem Mol Biol (2010) 0.78
A Bayesian goodness of fit test and semiparametric generalization of logistic regression with measurement data. Biometrics (2013) 0.78
Factors influencing the periodontal referral process. J Periodontol (2011) 0.77
Pth 1-84, Pth fragments and bone turnover. Am J Kidney Dis (2003) 0.77
Transactivation of the parathyroid hormone promoter by specificity proteins and the nuclear factor Y complex. Endocrinology (2005) 0.77
Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoter. Endocrinology (2003) 0.77
Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer. Endocrinology (2004) 0.76
A general approach to sample size determination for prevalence surveys that use dual test protocols. Biom J (2007) 0.76
Suppression of the human parathyroid hormone promoter by vitamin D involves displacement of NF-Y binding to the vitamin D response element. J Biol Chem (2004) 0.76
Parathyroid hormone type 1 receptor and human osteoclasts. J Bone Miner Res (2002) 0.75
Bone biopsy in patients with osteoporosis. Curr Osteoporos Rep (2007) 0.75
Diagnosis of low bone mass in CKD-5D patients. Clin Nephrol (2016) 0.75
Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients. PLoS One (2017) 0.75
Regression analysis using dependent Polya trees. Stat Med (2013) 0.75
Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms. Cancer Invest (2013) 0.75
Fatal anaphylactic shock in a patient undergoing hemodialysis via a polyurethane catheter. Clin Nephrol (2019) 0.75
PTH regulation of the human cytomegalovirus immediate-early gene promoter. Biochem Biophys Res Commun (2008) 0.75
Serum phosphorus adds to value of serum parathyroid hormone for assessment of bone turnover in renal osteodystrophy. Clin Nephrol (2016) 0.75
Coronary artery calcification in CKD-5D patients is tied to adverse cardiac function and increased mortality . Clin Nephrol (2016) 0.75
Mental Health Symptoms Among Student Service Members/Veterans and Civilian College Students. J Am Coll Health (2015) 0.75